π
|
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
11 auth.
R. Azziz,
E. Carmina,
D. Dewailly,
E. Diamanti-Kandarakis,
H. Escobar-Morreale,
W. Futterweit,
...
O. Janssen,
R. Legro,
R. Norman,
A. Taylor,
S. Witchel
|
10 |
2009 |
10 π
|
π
|
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
11 auth.
R. Azziz,
E. Carmina,
D. Dewailly,
E. Diamanti-Kandarakis,
H. Escobar-Morreale,
W. Futterweit,
...
O. Janssen,
R. Legro,
R. Norman,
A. Taylor,
S. Witchel
|
10 |
2006 |
10 π
|
π¦
|
Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
7 auth.
A. Taylor,
Brian McCourt,
K. Martin,
E. Anderson,
J. Adams,
D. Schoenfeld,
...
J. Hall
|
8 |
1997 |
8 π¦
|
π¬
|
Female reproductive aging is marked by decreased secretion of dimeric inhibin.
C. Welt,
Dennis J. McNicholl,
A. Taylor,
Janet E. Hall
|
8 |
1999 |
8 π¬
|
π¬
|
Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
J. Adams,
A. Taylor,
W. Crowley,
J. Hall
|
7 |
2004 |
7 π¬
|
π
|
Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.
8 auth.
C. Welt,
K. Martin,
A. Taylor,
G. Lambert-Messerlian,
W. Crowley,
Julie A. Smith,
...
D. Schoenfeld,
J. Hall
|
7 |
1997 |
7 π
|
π¦
|
A Clinical Guide for Contraception
A. Taylor
|
7 |
1993 |
7 π¦
|
π’
|
Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations.
7 auth.
A. Schneyer,
T. Fujiwara,
J. Fox,
C. Welt,
J. Adams,
G. Messerlian,
...
A. Taylor
|
6 |
2000 |
6 π’
|
π
|
Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy
9 auth.
M. Morrell,
J. IsojΓ€rvi,
A. Taylor,
M. Dam,
R. Ayala,
G. Gomez,
...
F. OβNeill,
P. Tennis,
J. Messenheimer
|
6 |
2003 |
6 π
|
π
|
On the Association Between Valproate and Polycystic OvaryβSyndrome
9 auth.
P. Genton,
J. Bauer,
S. Duncan,
A. Taylor,
A. Balen,
A. Eberle,
...
Birthe Pedersen,
X. Salas-Puig,
M. Sauer
|
6 |
2001 |
6 π
|
π
|
Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay.
8 auth.
G. Lambert-Messerlian,
Janet E. Hall,
P. Sluss,
A. Taylor,
Kathryn A. Martin,
Nigel P. Groome,
...
W. F. Crowley,
A. Schneyer
|
6 |
1994 |
6 π
|
π
|
Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
8 auth.
Robert J. Fountaine,
A. Taylor,
J. Mancuso,
F. Greenway,
L. Byerley,
Steven R Smith,
...
Marlene M. Most,
D. Fryburg
|
6 |
2010 |
6 π
|